Our Press Releases | Association for Accessible Medicines

Access! 2020 - Missed the early-bird? Save $300 off full-pass registration when you register by March 27

Dec 19, 2019 | Rachel Schwartz

USMCA Sets a New Standard for Lowering Drug Prices and Expanding Access to Medicines

Dec 17, 2019 | Rachel Schwartz

AAM Applauds House Passage of the CREATES Act

AAM Statement on H3

Dec 13, 2019 | Rachel Schwartz

AAM Statement on HR 3

Dec 10, 2019 | Rachel Schwartz

USMCA Trade Agreement: A Victory for America’s Patients

Dec 9, 2019 | Rachel Schwartz

AAM Opposes the Lower Health Care Costs Act

FDA - Nomination of Dr. Stephen Hahn to FDA

Nov 1, 2019 | Rachel Schwartz

AAM Statement on Nomination of Dr. Stephen Hahn to FDA

AAM Statement on 2019 FDA Drug Shortages

Oct 29, 2019 | Rachel Schwartz

AAM Statement on 2019 FDA Drug Shortages Task Force Report

Oct 23, 2019 | Rachel Schwartz

AAM Launches #DoesntAddUp Ad Campaign to Bring Down Prescription Drug Costs for Patients in the U.S.

Oct 16, 2019 | Rachel Schwartz

AAM Reaction to FDA Statement on Patient Access to Generic Drugs

California State Capitol - AB 824

Oct 8, 2019 | Rachel Schwartz

AAM Response to CA Governor Newsom Signing AB 824

Sep 20, 2019 | Rachel Schwartz

Seniors Denied Access to New, Lower-Priced Generic Drugs Due to Medicare Coverage Delays

Jul 23, 2019 | Rachel Schwartz

AAM Applauds Senate Finance’s Meaningful Effort to Reduce Drug Prices for America’s Patients